Identification of adducts formed in the reaction of 5'-acetoxy-N'-nitrosonornicotine with deoxyguanosine and DNA.

N'-Nitrosonornicotine (NNN) is believed to play an important role as a cause of cancer in people who use tobacco products and is considered to be a human carcinogen. NNN requires metabolism to form DNA adducts, which are absolutely critical to its carcinogenic properties. Previous studies have identified cytochrome P450-catalyzed 2'- and 5'-hydroxylation of NNN as potential DNA adduct forming metabolic pathways. 5'-Hydroxylation is the more prevalent of these in monkeys and humans and is known to generate mutagenic intermediates, but the DNA adducts formed by this pathway have never been characterized. In this study, we used 5'-acetoxyNNN as a stable precursor to 5'-hydroxyNNN and investigated its esterase-catalyzed reactions with deoxyguanosine (dGuo) and DNA. Adducts resulting from carbocation and oxonium ion intermediates, produced by the spontaneous decomposition of 5'-hydroxyNNN, were identified. The carbocation pathway resulted in the formation of 2-[2-hydroxy-5-(3-pyridyl)pyrrolidin-1-yl]deoxyinosine (12) which was characterized by comparison to an independently synthesized standard. Treatment of 12 with NaBH(3)CN produced two diastereomers of 2-[2-(3-pyridyl)pyrrolidin-1-yl]deoxyinosine (14), and their absolute configurations at the 2-position were determined by comparison to synthetic standards. The oxonium ion pathway produced diastereomers of N(2)[5-(3-pyridyl)tetrahydrofuran-2-yl]dGuo (16), identified by comparison to synthetic standards. The absolute configuration at the 5-position was determined by establishing the stereochemistry of the enantiomers of 5-(3-pyridyl)-2-hydroxytetrahydrofuran at the 5-position and allowing these to react individually with dGuo. Treatment of 16 with NaBH(3)CN produced N(2)[4-hydroxy-4-(3-pyridyl)but-1-yl]dGuo (18) which was also synthesized independently. Using liquid chromatography-electrospray ionization-tandem mass spectrometry with selected reaction monitoring, we identified adducts 12 and 16 as products of the reactions of 5'-acetoxyNNN with dGuo. Similarly, adducts 14 and 18 were identified as products of the reaction of 5'-acetoxyNNN with DNA followed by NaBH(3)CN treatment and enzymatic hydrolysis. These results provide the first structural characterization of DNA adducts that can be formed by 5'-hydroxylation of NNN.

[1]  S. Hecht,et al.  Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine. , 2005, Chemical research in toxicology.

[2]  S. Hecht,et al.  Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA. , 2004, Chemical research in toxicology.

[3]  Stephen S. Hecht,et al.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer , 2003, Nature Reviews Cancer.

[4]  Shana J Sturla,et al.  Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens. , 2003, Chemical research in toxicology.

[5]  N. Tretyakova,et al.  Identification of adducts produced by the reaction of 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanol with deoxyguanosine and DNA. , 2003, Chemical research in toxicology.

[6]  S. Hecht,et al.  Metabolism and pharmacokinetics of N'-nitrosonornicotine in the patas monkey. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[7]  L. Nechev,et al.  Stereospecific synthesis of oligonucleotides containing crotonaldehyde adducts of deoxyguanosine. , 2001, Chemical research in toxicology.

[8]  S. Hecht,et al.  Reactions of α-acetoxy-N-nitrosopyrrolidine with deoxyguanosine and DNA , 2001 .

[9]  S. Hecht,et al.  Reactions of 2,6-dimethyl-1,3-dioxane-4-ol (aldoxane) with deoxyguanosine and DNA. , 2001, Chemical research in toxicology.

[10]  S. Hecht,et al.  A Schiff base is a major DNA adduct of crotonaldehyde. , 2001, Chemical research in toxicology.

[11]  S. Hecht,et al.  Enantiomeric composition of N'-nitrosonornicotine and N'-nitrosoanatabine in tobacco. , 2000, Carcinogenesis.

[12]  S. Broyde,et al.  Principles Governing Conformations in Stereoisomeric Adducts of Bay Region Benzo[a]pyrene Diol Epoxides to Adenine in DNA: Steric and Hydrophobic Effects Are Dominant , 2000 .

[13]  S. Hecht,et al.  Metabolism of N'-nitrosonornicotine enantiomers by cultured rat esophagus and in vivo in rats. , 2000, Chemical research in toxicology.

[14]  S. Hecht,et al.  Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats. , 1999, Chemical research in toxicology.

[15]  D. Hatsukami,et al.  Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: A substantial pathway of nicotine metabolism. , 1999, Chemical research in toxicology.

[16]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[17]  A. Dipple,et al.  DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. , 1998, Chemical research in toxicology.

[18]  S. Hecht,et al.  Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2000, Carcinogenesis.

[19]  D. Patel,et al.  NMR solution structures of stereoisometric covalent polycyclic aromatic carcinogen-DNA adduct: principles, patterns, and diversity. , 1997, Chemical research in toxicology.

[20]  S. Amin,et al.  Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[21]  P. Crooks,et al.  Regioselective Alkylation of N‐(diphenylmethylidine)‐3‐(aminomethyl) pyridine: A Simple Route to Minor Tobacco Alkaloids and Related Compounds. , 1996 .

[22]  P. Crooks,et al.  REGIOSELECTIVE ALKYLATION OF N-(DIPHENYLMETHYLIDINE)-3-(AMINOMETHYL)PYRIDINE : A SIMPLE ROUTE TO MINOR TOBACCO ALKALOIDS AND RELATED COMPOUNDS , 1996 .

[23]  J. Schwab,et al.  UNPRECEDENTED OBSERVATION OF LACTONE HYDROLYSIS BY THE AAL2 MECHANISM , 1991 .

[24]  S. Hecht,et al.  Analysis for N2-(pyridyloxobutyl)deoxyguanosine adducts in DNA of tissues exposed to tritium-labeled 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine. , 1989, Chemical research in toxicology.

[25]  D. Bleyl,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr , 1989 .

[26]  D Hoffmann,et al.  The relevance of tobacco-specific nitrosamines to human cancer. , 1989, Cancer surveys.

[27]  S. Hecht,et al.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. , 1988, Carcinogenesis.

[28]  S. Hecht,et al.  Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. , 1986, Cancer research.

[29]  Xinxin Ding,et al.  4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). , 2011, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[30]  J. I. Seeman,et al.  Synthesis of the enantiomers of nornicotine , 1985 .

[31]  S. Hecht,et al.  A study of chemical carcinogenesis. 14. Hydrolysis of model compounds for .alpha.-hydroxylation of the carcinogens N-nitrosopyrrolidine and N'-nitrosonornicotine , 1979 .

[32]  S. Hecht,et al.  Metabolic α-Hydroxylation of the Tobacco-specific Carcinogen, N′-Nitrosonornicotine , 1978 .

[33]  H. J. J. Loozen,et al.  A NOVEL AND EFFICIENT ROUTE TO 5-ARYLATED GAMMA-LACTONES , 1975 .

[34]  H. J. J. Loozen,et al.  Novel and efficient route to 5-arylated .gamma.-lactones , 1975 .